drugset / Trial / NCT05730413

Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery

NCT05730413

Phase 4 Unknown 122 enrolled Cairo University
RandomizedParallel-groupOpen-labelPrevention

Summary

The goal of this interventional clinical trial is compare between two different dose regimens of bisoprolol (beta-blocker) in CABG patients in terms of efficacy and safety.

Timeline

Start
2021-08-25
Primary completion
2023-09
Completion
2023-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bisoprolol Other / unclassified 2.5 mg
Comparator Bisoprolol Other / unclassified 5 mg